References
- Adachi R, Horiuchi S, Sakurazawa Y, et al (2011). ErbB2 downregulates microRNA-205 in breast cancer. Biochem Biophys Res Commun, 411, 804-8. https://doi.org/10.1016/j.bbrc.2011.07.033
- American Cancer Society (2007). Cancer facts and figures 2007, Atlanta, Ga, USA.
- Babak T, Zhang W, Morris Q, Blencowe BJ, Hughes TR (2004). Probing microRNAs with microarrays: tissue specificity and functional inference. RNA, 10, 1813-9. https://doi.org/10.1261/rna.7119904
- Benjamini Ya , Hochberg Y (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B, 57, 289-300.
- Bishop JA, Benjamin H, Cholakh H, et al (2010). Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res, 16, 610-9. https://doi.org/10.1158/1078-0432.CCR-09-2638
- Blenkiron C, Goldstein LD, Thorne NP, et al (2007). MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol, 8, 214. https://doi.org/10.1186/gb-2007-8-5-214
- Blot WJ, Devesa SS, Fraumeni JF Jr (1993). Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA, 270, 1320.
- Boll K, Reiche K, Kasack K, et al (2013). MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma. Oncogene, 32, 277-85. https://doi.org/10.1038/onc.2012.55
- Boren T, Xiong Y, Hakam A, et al (2008). MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. Gynecol Oncol, 110, 206-15. https://doi.org/10.1016/j.ygyno.2008.03.023
- Cai Y, Yu X, Hu S, Yu J (2009). A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics, 7, 147-54. https://doi.org/10.1016/S1672-0229(08)60044-3
- Calin GA, Sevignani C, Dumitru CD, et al (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A, 101, 2999-3004. https://doi.org/10.1073/pnas.0307323101
- Campobasso O, Andrion A, Ribotta M, Ronco G (1993). The value of the 1981 WHO histological classification in interobserver reproducibility and changing pattern of lung cancer. Int J Cancer, 53, 205-8. https://doi.org/10.1002/ijc.2910530205
- Chaffer CL, Weinberg RA (2011). A perspective on cancer cell metastasis. Science, 331, 1559-64. https://doi.org/10.1126/science.1203543
- Chang CJ, Hsu CC, Chang CH, et al (2011). Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer. Oncol Rep, 26, 1003-10.
- Chekulaeva M, Filipowicz W (2009). Mechanisms of miRNAmediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol, 21, 452-60. https://doi.org/10.1016/j.ceb.2009.04.009
- Childs G, Fazzari M, Kung G, et al (2009). Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol, 174, 736-45. https://doi.org/10.2353/ajpath.2009.080731
- Chung TK, Cheung TH, Huen NY, et al (2009). Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women. Int J Cancer, 124, 1358-65. https://doi.org/10.1002/ijc.24071
- Croce CM (2012). 37 Causes and Consequences of microRNA Dysregulation in Cancer. Eur J Cancer, 48, 8-9.
- Cohen MH, Gootenberg J, Keegan P, Pazdur R (2007). FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer. Oncologist, 12, 713-8. https://doi.org/10.1634/theoncologist.12-6-713
- Cohn DE, Fabbri M, Valeri N, et al (2010). Comprehensive miRNA profiling of surgically staged endometrial cancer. Am J Obstet Gynecol, 202, 1-8. https://doi.org/10.1016/j.ajog.2009.08.028
- CufiS, Vazquez-Martin A, Oliveras-Ferraros C, et al (2012). Metformin lowers the threshold for stress-induced senescence: a role for the microRNA-200 family and miR-205. Cell Cycle, 11, 1235-46. https://doi.org/10.4161/cc.11.6.19665
- Dar AA, Majid S, de Semir D, et al (2011). miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J Biol Chem, 286, 16606-14. https://doi.org/10.1074/jbc.M111.227611
- Darnell DK, Kaur S, Stanislaw S, et al (2006). MicroRNA expression during chick embryo development. Dev. Dyn, 235, 3156-65. https://doi.org/10.1002/dvdy.20956
- Dip N, Reis ST, Timoszczuk LS, et al (2012). Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile. J Urol, 188, 1951-6. https://doi.org/10.1016/j.juro.2012.07.004
- Fabian MR, Sundermeier TR, Sonenberg N (2010). Understanding how miRNAs post-transcriptionally regulate gene expression. Prog Mol Subcell Biol, 50, 1-20. https://doi.org/10.1007/978-3-642-03103-8_1
- Fassina A, Cappellesso R, Guzzardo V, et al (2012). Epithelialmesenchymal transition in malignant mesothelioma. Mod Pathol, 25, 86-99. https://doi.org/10.1038/modpathol.2011.144
- Feber A, Xi L, Luketich JD, et al (2008). MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg, 135, 255-60. https://doi.org/10.1016/j.jtcvs.2007.08.055
- Feber A, Xi L, Pennathur A, et al (2011). MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. Ann Thorac Surg, 91, 1523-30. https://doi.org/10.1016/j.athoracsur.2011.01.056
- Fletcher AM, Heaford AC, Trask DK (2008). Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir-205. Transl Oncol, 1, 202-8. https://doi.org/10.1593/tlo.08163
- Gandellini P, Folini M, Longoni N, et al (2009). miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res, 69, 2287-95. https://doi.org/10.1158/0008-5472.CAN-08-2894
- Gandellini P, Profumo V, Casamichele A, et al (2012). miR-205 regulates basement membrane deposition in human prostate: implications for cancer development. Cell Death Differ, 19, 1750-60. https://doi.org/10.1038/cdd.2012.56
- Ginos MA, Page GP, Michalowicz BS, et al (2004). Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res, 64, 55-63. https://doi.org/10.1158/0008-5472.CAN-03-2144
- Gottardo F, Liu CG, Ferracin M, et al (2007). Micro-RNA profiling in kidney and bladder cancers. Urol Oncol, 25, 387-92. https://doi.org/10.1016/j.urolonc.2007.01.019
- Greene SB, Gunaratne PH, Hammond SM, Rosen JM (2010a). A putative role for microRNA-205 in mammary epithelial cell progenitors. J Cell Sci, 123, 606-18. https://doi.org/10.1242/jcs.056812
- Greene SB, Herschkowitz JI, Rosen JM (2010b). The ups and downs of miR-205: identifying the roles of miR-205 in mammary gland development and breast cancer. RNA Biol, 7, 300-4. https://doi.org/10.4161/rna.7.3.11837
- Gregory PA, Bert AG, Paterson EL, et al (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 10, 593-601. https://doi.org/10.1038/ncb1722
- Gu J, Wang Y, Wu X (2013). MicroRNA in the pathogenesis and prognosis of esophageal cancer. Curr Pharm Des, 19, 1292-300.
- Hagman Z, Haflidadottir BS, Ceder JA, et al (2013). miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients. Br J Cancer, 108, 1668-76. https://doi.org/10.1038/bjc.2013.131
- Hamamoto J, Soejima K, Yoda S, et al (2013). Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma. Mol Med Rep, 8, 456-62.
- Hesketh PJ, Clapp RW, Doos WG, Spechler SJ (1989). The increasing frequency of adenocarcinoma of the esophagus. Cancer, 64, 526-30. https://doi.org/10.1002/1097-0142(19890715)64:2<526::AID-CNCR2820640228>3.0.CO;2-B
- Hiroki E, Akahira J, Suzuki F, et al (2010). Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci, 101, 241-9. https://doi.org/10.1111/j.1349-7006.2009.01385.x
- Iorio MV, Croce CM (2009). MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol, 27, 5848-56. https://doi.org/10.1200/JCO.2009.24.0317
- Iorio MV, Casalini P, Piovan C, et al (2009). microRNA-205 regulates HER3 in human breast cancer. Cancer Res, 69, 2195-200. https://doi.org/10.1158/0008-5472.CAN-08-2920
- Iorio MV, Ferracin M, Liu CG, et al (2005 ). MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 65, 7065-70. https://doi.org/10.1158/0008-5472.CAN-05-1783
- Iorio MV, Visone R, Di Leva G, et al (2007). MicroRNA signatures in human ovarian cancer. Cancer Res, 67, 8699-707. https://doi.org/10.1158/0008-5472.CAN-07-1936
- Jansson MD, Lund AH (2012). MicroRNA and cancer. Mol Oncol, 6, 590-610. https://doi.org/10.1016/j.molonc.2012.09.006
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90 https://doi.org/10.3322/caac.20107
- Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49. https://doi.org/10.3322/caac.20006
- Jiang J, Lee EJ, Gusev Y, Schmittgen TD (2005). Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res, 33, 5394-403. https://doi.org/10.1093/nar/gki863
- Kalluri R, Weinberg RA (2009). The basics of epithelialmesenchymal transition. J Clin Invest, 119, 1420-8. https://doi.org/10.1172/JCI39104
- Karaayvaz M, Zhang C, Liang S, Shroyer KR, Ju J (2012). Prognostic significance of miR-205 in endometrial cancer. PLoS One, 7, 35158. https://doi.org/10.1371/journal.pone.0035158
- Kimura S, Naganuma S, Susuki D, et al (2010). Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep, 23, 1625-33.
- Kong D, Suzuki A, Zou TT, et al (1997). PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet, 17, 143-4. https://doi.org/10.1038/ng1097-143
- Landgraf P, Rusu M, Sheridan R, et al (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell, 129, 1401-14. https://doi.org/10.1016/j.cell.2007.04.040
- Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP (2003). Vertebrate microRNA genes. Science, 299, 1540. https://doi.org/10.1126/science.1080372
- Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8. https://doi.org/10.1038/nature03702
- Majid S, Dar AA, Saini S, et al (2010). MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer, 116, 5637-49. https://doi.org/10.1002/cncr.25488
- Majid S, Saini S, Dar AA, et al (2011). MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. Cancer Res, 71, 2611-21. https://doi.org/10.1158/0008-5472.CAN-10-3666
- Matsushima K, Isomoto H, Kohno S, Nakao K (2010). MicroRNAs and esophageal squamous cell carcinoma. Digestion, 82, 138-44. https://doi.org/10.1159/000310918
- Matsushima K, Isomoto H, Yamaguchi N, et al (2011). MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells. J Transl Med, 9, 30. https://doi.org/10.1186/1479-5876-9-30
- Mimeault M, Batra SK (2006). Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies. Carcinogenesis, 27, 1-22.
- Muratsu-Ikeda S, Nangaku M, Ikeda Y, et al (2012). Downregulation of miR-205 modulates cell susceptibility to oxidative and endoplasmic reticulum stresses in renal tubular cells. PLoS One, 7, 41462. https://doi.org/10.1371/journal.pone.0041462
- Neely LA, Rieger-Christ KM, Neto BS, et al (2010). A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol, 28, 39-48. https://doi.org/10.1016/j.urolonc.2008.06.006
- Pfaff J, Meister G (2013). Argonaute and GW182 proteins: an effective alliance in gene silencing. Biochem Soc Trans, 41, 855-60. https://doi.org/10.1042/BST20130047
- Piovan C, Palmieri D, Di Leva G, et al (2012). Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer. Mol Oncol, 6, 458-72. https://doi.org/10.1016/j.molonc.2012.03.003
- Qu C, Liang Z, Huang J, et al (2012). miR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle, 11, 785-96. https://doi.org/10.4161/cc.11.4.19228
- Radojicic J, Zaravinos A, Vrekoussis T, et al (2011). MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer. Cell Cycle, 10, 507-17. https://doi.org/10.4161/cc.10.3.14754
- Ralfkiaer U HP, Bangsgaard N, Lovendorf MB, et al (2011). Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood, 118, 5891-900. https://doi.org/10.1182/blood-2011-06-358382
- Ratner ES, Tuck D, Richter C, et al (2010). MicroRNA signatures differentiate uterine cancer tumor subtypes. Gynecol Oncol, 118, 251-7. https://doi.org/10.1016/j.ygyno.2010.05.010
- Risinger JI, Hayes AK, Berchuck A, Barrett JC (1997). PTEN/ MMAC1 mutations in endometrial cancers. Cancer Res, 57, 4736-8.
- Saad R, Chen Z, Zhu S, et al (2013). Deciphering the unique microRNA signature in human esophageal adenocarcinoma. PLoS One, 8, 64463. https://doi.org/10.1371/journal.pone.0064463
- Said NA, Simpson KJ, Williams ED (2013). Strategies and challenges for systematically mapping biologically significant molecular pathways regulating carcinoma epithelial-mesenchymal transition. Cells Tissues Organs, 197, 424-34. https://doi.org/10.1159/000351717
- Savad S, Mehdipour P, Miryounesi M, et al ( 2012). Expression analysis of MiR-21, MiR-205, and MiR-342 in breast cancer in Iran. Asian Pac J Cancer Prev, 13, 873-7. https://doi.org/10.7314/APJCP.2012.13.3.873
- Sempere LF, Christensen M, Silahtaroglu A, et al (2007). Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res, 67, 11612-20. https://doi.org/10.1158/0008-5472.CAN-07-5019
- Sevignani C, Calin GA, Siracusa LD, Croce CM (2006). Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome, 17, 189-202. https://doi.org/10.1007/s00335-005-0066-3
- Shah MA, Kurtz RC (2010). Upper gastrointestinal cancer predisposition syndromes. Hematol Oncol Clin North Am, 24, 815-35. https://doi.org/10.1016/j.hoc.2010.06.007
- Shingara J, Keiger K, Shelton J, et al (2005). An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA, 11, 1461-70. https://doi.org/10.1261/rna.2610405
- Siegel R, Naishadham D, Jemal A. (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
- Snowdon J, Zhang X, Childs T, Tron VA, Feilotter H (2011). The microRNA-200 family is upregulated in endometrial carcinoma. PLoS One, 6.
- Solomides CC, Evans BJ, Navenot JM, et al (2012). MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis. Acta Cytol, 56, 645-4. https://doi.org/10.1159/000343473
- Song H, Bu G (2009). MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1. Biochem Biophys Res Commun, 388, 400-5. https://doi.org/10.1016/j.bbrc.2009.08.020
- Stang A, Pohlabeln H, Muller KM, et al (2006). Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case-control study. Lung Cancer, 52, 29-36. https://doi.org/10.1016/j.lungcan.2005.11.012
- Su N, Qiu H, Chen Y, et al (2013). miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma. Oncol Rep, 29, 2297-302.
- Suzuki H, Maruyama R, Yamamoto E, Kai M(2012). DNA methylation and microRNA dysregulation in cancer. Mol Oncol, 6, 567-78. https://doi.org/10.1016/j.molonc.2012.07.007
- Tashiro H, Blazes MS, Wu R, et al (1997). Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res, 57, 3935-40.
-
Tran MN, Choi W, Wszolek MF, et al (2013). The p63 protein isoform
$\Delta{Np63}\alpha$ inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. J Biol Chem, 288, 3275-88. https://doi.org/10.1074/jbc.M112.408104 - Tran N, McLean T, Zhang X, et al (2007). MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun, 358, 12-7. https://doi.org/10.1016/j.bbrc.2007.03.201
- Verdoodt B, Neid M, Vogt M, et al (2013). MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer. Int J Oncol, 43, 307-14.
- Volinia S, Calin GA, Liu CG, et al (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A, 103, 2257-61. https://doi.org/10.1073/pnas.0510565103
- Vosa U, Vooder T, Kolde R, et al (2013). Meta-analysis of microRNA expression in lung cancer. Int J Cancer, 132, 2884-93. https://doi.org/10.1002/ijc.27981
- Wang D, Qiu C, Zhang H, et al (2010). Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets. PLoS One, 5, 13067. https://doi.org/10.1371/journal.pone.0013067
- Wang G, Chan ES, Kwan BC, et al (2012). Expression of microRNAs in the urine of patients with bladder cancer. Clin Genitourin Cancer, 10, 106-13. https://doi.org/10.1016/j.clgc.2012.01.001
- Wang WX, Wilfred BR, Hu Y, Stromberg AJ, Nelson PT (2010). "Anti-Argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes." RNA, 16, 394-404. https://doi.org/10.1261/rna.1905910
- Wienholds E, Kloosterman WP, Miska E, et al (2005). MicroRNA expression in zebrafish embryonic development. Science, 309, 310-1. https://doi.org/10.1126/science.1114519
- Wiklund ED, Bramsen JB, Hulf T, et al (2011). Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer, 128, 1327-34. https://doi.org/10.1002/ijc.25461
- Witten D, Tibshirani R, Gu SG, Fire A, Lui WO (2010). Ultrahigh throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol, 8.
- Wu H, Zhu S, Mo YY (2009). Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res, 19, 439-48. https://doi.org/10.1038/cr.2009.18
- Wu W, Lin Z, Zhuang Z, Liang X (2009). Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. Eur J Cancer Prev, 18, 50-5.
- Xie H, Zhao Y, Caramuta S, Larsson C, Lui WO (2012). miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PLoS One, 7.
- Xing L, Todd NW, Yu L, Fang H, Jiang F (2010). Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol, 23, 1157-64. https://doi.org/10.1038/modpathol.2010.111
- Xu Y, Brenn T, Brown ER, Doherty V, Melton DW (2012). Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. Br J Cancer, 106, 553-61. https://doi.org/10.1038/bjc.2011.568
- Yanaihara N, Caplen N, Bowman E, et al (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9, 189-98. https://doi.org/10.1016/j.ccr.2006.01.025
- Yu J, Ryan DG, Getsios S, et al (2008). MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia. Proc Natl Acad Sci U S A, 105, 19300-5. https://doi.org/10.1073/pnas.0803992105
- Yu L, Todd NW, Xing L, et al (2010). Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer, 127, 2870-8. https://doi.org/10.1002/ijc.25289
- Zhang B, Pan X, Cobb GP, Anderson TA (2007). microRNAs as oncogenes and tumor suppressors. Dev Biol, 302, 1-12. https://doi.org/10.1016/j.ydbio.2006.08.028
- Zhu QC, Gao RY, Wu W, Qin HL (2013). Epithelialmesenchymal Transition and Its Role in the Pathogenesis of Colorectal Cancer. Asian Pac J Cancer Prev, 14, 2689-98. https://doi.org/10.7314/APJCP.2013.14.5.2689
- Zidar N, Bostjancic E, Gale N, et al (2011). Down-regulation of microRNAs of the miR-200 family and miR-205, and an altered expression of classic and desmosomal cadherins in spindle cell carcinoma of the head and neck-hallmark of epithelial-mesenchymal transition. Hum Pathol, 42, 482-8 https://doi.org/10.1016/j.humpath.2010.07.020
Cited by
- TRAIL Based Therapy: Overview of Mesenchymal Stem Cell Based Delivery and miRNA Controlled Expression of TRAIL vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6495
- MicroRNAs in Colorectal Cancer: from Diagnosis to Targeted Therapy vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.6989
- MicroRNAs: Biogenesis, Roles for Carcinogenesis and as Potential Biomarkers for Cancer Diagnosis and Prognosis vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7489
- miR-205 in Situ Expression and Localization in Head and Neck Tumors - a Tissue Array Study vol.15, pp.21, 2014, https://doi.org/10.7314/APJCP.2014.15.21.9071
- Diagnostic and Prognostic Value of miR-205 in Colorectal Cancer vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.4033
- Mechanisms of miRNA-Mediated Gene Regulation from Common Downregulation to mRNA-Specific Upregulation vol.2014, pp.2314-4378, 2014, https://doi.org/10.1155/2014/970607
- Prognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer vol.11, pp.10, 2016, https://doi.org/10.1371/journal.pone.0164687
- Mesenchymal to Epithelial Transition Induced by Reprogramming Factors Attenuates the Malignancy of Cancer Cells vol.11, pp.6, 2016, https://doi.org/10.1371/journal.pone.0156904
- MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus vol.37, pp.6, 2016, https://doi.org/10.1007/s13277-015-4656-8
- Renal epithelial miR-205 expression correlates with disease severity in a mouse model of congenital obstructive nephropathy vol.80, pp.4, 2016, https://doi.org/10.1038/pr.2016.121
- MicroRNAs: Clinical Trials and Potential Applications vol.21, pp.5, 2017, https://doi.org/10.1188/17.CJON.554-559
- ) -Promoted Cancer Cell Migration vol.35, pp.9, 2017, https://doi.org/10.1080/07357907.2017.1378671
- Differential expression and androgen regulation of microRNAs and metalloprotease 13 in breast cancer cells vol.41, pp.12, 2017, https://doi.org/10.1002/cbin.10841
- Long-term exposure of MCF-12A normal human breast epithelial cells to ethanol induces epithelial mesenchymal transition and oncogenic features vol.48, pp.6, 2016, https://doi.org/10.3892/ijo.2016.3461
- The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma pp.1432-1335, 2018, https://doi.org/10.1007/s00432-018-2755-9
- Low let-7d and high miR-205 expression levels positively influence HNSCC patient outcome vol.26, pp.1, 2019, https://doi.org/10.1186/s12929-019-0511-3